Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.

Bernath MM, Brosch J, Saykin AJ, Wilcock D, Summanwar D, Willis DR

Open source

DOI
10.1002/alz.71769
Published
2026 Aug
Container
Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/alz.71769,
  title = {Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.},
  author = {Bernath MM and Brosch J and Saykin AJ and Wilcock D and Summanwar D and Willis DR},
  year = {2026},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.71769},
  url = {https://doi.org/10.1002/alz.71769}
}

RIS

TY  - JOUR
TI  - Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.
AU  - Bernath MM
AU  - Brosch J
AU  - Saykin AJ
AU  - Wilcock D
AU  - Summanwar D
AU  - Willis DR
PY  - 2026
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.71769
UR  - https://doi.org/10.1002/alz.71769
ER  - 

APA

MM, B., J, B., AJ, S., D, W., D, S., & DR, W. (2026). Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71769

Source records